• OPEN AN ACCOUNT
Indian Indices
Sensex
78,428.95 -210.08
( -0.27%)
Global Indices
Nasdaq
54,113.09 913.68
(1.72%)
Dow Jones
7,758.57 137.07
(1.80%)
Hang Seng
63,983.92 229.02
(0.36%)
Nikkei 225
10,890.39 32.69
(0.30%)
Forex
USD-INR
95.40 -0.19
(-0.20%)
EUR-INR
110.00 0.21
(0.19%)
GBP-INR
128.60 0.50
(0.39%)
JPY-INR
0.61 0.01
(2.47%)

EQUITY - MARKET SCREENER

Kobo Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
531541
INE881A01015
-57.9811542
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
18.32
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Avantel gains after bagging Rs 10-cr DRDO contract for GSAT satellite terminals
Jun 09,2026
The contract includes a warranty period of 24 months. According to the company, the project is scheduled to be completed by December 2028.

Avantel is engaged in the business of designing, developing, and maintaining wireless and satellite communication products, defence electronics, radar systems, and the development of network management software applications for its customers, mainly from the aerospace and defence sectors.

The company reported a 21.5% year-on-year decline in consolidated net profit to Rs 4.77 crore in Q4 FY26, compared with Rs 6.08 crore in Q4 FY25. Revenue from operations rose 29.6% year-on-year to Rs 63.83 crore in Q4 FY26.